Teledyne Technologies reports decline in net income
Thousand-Oaks based Teledyne Technologies reported a drop in net income for its fiscal year 2016 over the prior year, with a 7 percent fourth quarter drop in sales to $552.9 million. Net income from continuing operations came to $192.9 million, or $5.43 per diluted share, compared to $198 million in 2015, while total sales fell Read More →
Agilent cancer treatment approved in Europe
Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →
Europeans recommend approval of Amgen’s biosimilar of AbbVie’s Humira
The European Medicines Agency recommended the approval of the ABP 501, a biosimilar of AbbVie’s Humira (adalimumab), for treatment of inflammatory diseases, Thousand Oaks-based biotech company Amgen announced on Jan. 27. The EMA recommended ABP 501’s use for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, severe ankylosing spondylitis, severe axial spondyloarthritis without radiographic evidence of AS, moderate-to-severe Read More →
Cynvenio inks deal with Milenia Labs to distribute blood test
Westlake Village cancer treatment company Cynvenio Biosystems announced an exclusive agreement with diagnostic test company Milenia Labs to distribute a blood test for breast cancer at its 12 diagnostic centers in Mexico. Financial details of the deal were not disclosed. The test provides real-time information about cancer cell activity for patients who have completed treatment Read More →
Digital West completes merger with Norcast Telecom
Digital West announced Jan. 24 that it completed a merger with its fellow IT network provider Norcast Telecom, both headquartered in San Luis Obispo. Together, they will have 60 employees with no staff reductions planned. “Our two companies have worked closely for more than 10 years; in fact, we work with many of the same Read More →









